Lung Cancer Clinical Trials

Showing 4141-4160 of 4,288 trials

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

NCT01081496

To estimate the prevalence of EGFR mutation in a representative sample of patients with newly diagnosed stage IIIB/IV NSCLC in Spain (predominantly Caucasian ethnicity).

Non Small Cell Lung Cancer

AstraZeneca1,000 participantsStarted Mar 2010

Santiago de Compostela, A Coruna, Spain • Albacete, Albacete, Spain • Alicante, Alicante, Spain +21 more locations

COMPLETEDPhase 1

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00023985

RATIONALE: Vaccines made from a person's tumor cells and white blood cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have non-small cell lung cancer.

Lung Cancer

Roswell Park Cancer InstituteStarted Jan 2001

Buffalo, New York, United States

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Related Searches

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Iressa Case Control Study in Japan

The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism

Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer

An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC

Chemotherapy for Patients With Non-Small Cell Lung Cancer

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma